Due to population aging, the prevalence of dementia in long-term care (LTC) has increased (Falzarano et al., 2022). Full Story
The tragic circumstances surrounding the deaths of actor Gene Hackman and his wife, Betsy Arakawa, have drawn attention to the arduous role of caring for loved ones with dementia. Full…
If there’s one word to describe the spirit of my two middle boys, it would be “serendipitous.” They float through life with a carefree lightness that many envy, leaving behind…
In an interview with Pharmacy Times®, Paul Edison, MBBS, PhD, FRCPI, professor of neurology at Imperial College London, discusses the potential of GLP-1 analogs in treating Alzheimer disease (AD), highlighting…
Join us at the Lander Library on Thursday, April 10th at 6 PM to kick off our Good Stewards Series with a presentation from the Alzheimer’s Association. Learn about the…
Ten million people are diagnosed with dementia worldwide each year – that’s more than ever. According to the Alzheimer’s Society, approximately one million people in the UK are currently living…
The legislation would require insurance plans provided through the state’s system to cover FDA-approved treatments for early-stage Alzheimer’s. Full Story
Porosome Therapeutics Inc. has announced a major breakthrough in Alzheimer’s disease (AD) research, identifying the secretory dysfunction responsible for the disease and developing advanced therapeutic neuronal nanomachines. Full Story
A newly developed blood test may soon transform the clinical assessment of Alzheimer’s disease, offering not only a means to detect the condition but also a way to measure how…
Researchers in Newcastle have been awarded £1.6 million to develop a network which will support people living with dementia by connecting existing technology and services. Full Story